Showing results (2561-2570 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|April 16, 2024
Synthesis of Rupestonic Acid L-Ephedrine Derivatives with Preliminary In vitro Anti-influenza Viral ActivityJianping Yong, Canzhong LuCurrent Pharmaceutical Design|December 31, 2013
ATP synthesis revisited: new avenues for the management of mitochondrial diseasesGeorgios Bagkos, Kostas Koufopoulos, Christina PiperiCurrent Pharmaceutical Design|December 31, 2013
Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteersPatrick Lyden, Howard Levy, Sara Weymer, et al.Current Pharmaceutical Design|November 20, 2013
Can mycobacterial genomics generate novel targets as speed-breakers against the race for drug resistanceR S Chauhan, S K Chanumolu, Chittaranjan Rout, et al.Current Pharmaceutical Design|November 20, 2013
New approaches to tuberculosis--novel drugs based on drug targets related to toll-like receptors in macrophagesHaruaki TomiokaCurrent Pharmaceutical Design|September 6, 2014
Potential application of antimicrobial peptides in the treatment of bacterial biofilm infectionsNikola Strempel, Janine Strehmel, Joerg OverhageCurrent Pharmaceutical Design|September 6, 2014
Strategies for antimicrobial drug delivery to biofilmClaire Martin, Wan Li Low, Abhishek Gupta, et al.Current Pharmaceutical Design|August 28, 2014
Emerging biology of PDE10ALindsay S Wilson, Nicholas J BrandonCurrent Pharmaceutical Design|August 28, 2014
Role of phosphodiesterase 4-mediated cyclic AMP signaling in pharmacotherapy for substance dependenceRui-Ting Wen, Wan-Yu Feng, Jian-Hui Liang, et al.Current Pharmaceutical Design|August 28, 2014
Phosphodiesterase inhibitors as therapeutics for traumatic brain injuryDavid J Titus, Anthony A Oliva, Nicole M Wilson, et al.Pageof 1,008